New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
05:19 EDTWOPEY, RDS.AShell reduces interest in Woodside Petroleum by 156.5M shares
Shell (RDS.A) announced the sale of a total of approximately 156.5M shares in Woodside Petroleum (WOPEY) representing a total estimated value to Shell of around $5B on an after tax basis. The sale, which represents 19% of Woodside's issued share capital, is through an underwritten sell-down to equity market investors and a selective share buy-back by Woodside. Shell's subsidiary, Shell Energy Holding Australia, or SEHAL, has mandated two investment banks to sell 78.27M shares in Woodside, through an underwritten sell-down at a price of A$41.35 per share. This part of the sale represents around 9.5% of the issued capital in Woodside, with the shares to be sold to a range of equity market investors. The sell-down is expected to complete on June 18. Under an agreement with SEHAL, Woodside will also buy-back 78.27M of its shares from SEHAL at a price of $34.24 per share. The buy-back price per share has been split into a dividend component of $26.29 per share and a capital component of $7.95 per share, as agreed with the Australian Taxation Office in a private ruling. SEHAL will receive franking credits on the dividend component with the effect that no further tax is payable by SEHAL on the dividend component. Completion of the buy-back will be subject to limited conditions, including consent under a number of Woodside's facility agreements, an independent expert opinion and Woodside shareholder approval. Completion of the buy-back is expected in early August.
News For A;WOPEY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
11:01 EDTAAgilent partners with Weill Cornell Medical College for ALS research
Subscribe for More Information
August 17, 2015
17:48 EDTAAgilent says confident in delivering on margin expansion goals
On the company Q3 earnings conference call, Agilent said that it is confident in delivering on margin expansion goals. The company noted that it is committed to a 22% operating margin by 2017 and will continue its buybacks in Q4. The company sees a number of areas of strength including Pharma, Life Science, Research and Diagnostics. The company is seeing double-digit growth in Pharma and has no reason to believe it will slow down. Agilent sees "a lot " of reasons to be positive on outlook.
16:21 EDTAAgilent says some U.S. and state government large deals delayed into Q4
Agilent said in a slides presentation that some US and state government large deals delayed into Q4. Customers in industrial markets continue cautious stance in light of macro-economic conditions.
16:09 EDTAAgilent narrows FY15 EPS view to $1.68-$1.72 from $1.67- $1.73
Subscribe for More Information
16:07 EDTAAgilent sees Q4 EPS 45c-49c, consensus 50c
Sees Q4 revenue $1.03B-$1.05B, consensus $1.06B.
16:06 EDTAAgilent reports Q3 EPS 44c, consensus 41c
Subscribe for More Information
14:48 EDTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Agilent (A), consensus 41c... Urban Outfitters (URBN), consensus 49c... MasTec (MTZ), consensus 15c... Fabrinet (FN), consensus 39c.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use